Quick Takeaways
- Qiming U.S. Healthcare Fund II, L.P. filed SCHEDULE 13G/A for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 (JSPR).
- Disclosed ownership: 3.3%.
- Date of event: 30 Sep 2025.
Qiming U.S. Healthcare Fund II, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 (JSPR)
- Filing Manager
- Qiming U.S. Healthcare Fund II, L.P.
- Reporting Manager
- Qiming U.S. Healthcare Fund II, L.P.
- Symbol
- JSPR
- Shares outstanding
- 28,150,424 shares
- Disclosed Ownership
- 928,964 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 17:22:30 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Qiming U.S. Healthcare Fund II, L.P. disclosed 3.3% ownership in Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 (JSPR) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 17:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund II, L.P. | 3.3% | 928,964 | 0 | 928,964 | /s/ Mark McDade | By Qiming U.S. Healthcare GP II, LLC, its general partner, By Mark McDade, Managing Partner | |
| Qiming U.S. Healthcare GP II, LLC | 3.3% | 928,964 | 0 | 928,964 | /s/ Mark McDade | Mark McDade, Managing Partner | |
| Mark McDade | 3.3% | 928,964 | 0 | 928,964 | /s/ Mark McDade | Mark McDade | |
| GARY E RIESCHEL | 3.3% | 928,964 | 0 | 928,964 | /s/ Gary Rieschel | Gary Rieschel |